Skip to content

Establishment of epigenetic approach to identify high risk patients of colorectal cancer in ulcerative colitis

Establishment of epigenetic approach to identify high risk patients of colorectal cancer in ulcerative colitis - Identifying high risk patients of colorectal cancer in ulcerative colitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036203
Enrollment
200
Registered
2019-03-15
Start date
2019-03-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Interventions

None listed

Sponsors

Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Longstanding ulcerative colitis patients who need screening colonoscopy

Exclusion criteria

Exclusion criteria: Ulcerative patients less than 20 years Ulcerative patients without ability for judgment

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy of DNA methylation analysis for ulcerative colitis patients complicated with colorectal cancer using rectal mucosa from ulcerative colitis

Countries

Japan

Contacts

Public ContactYuji Toiyama

Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medic Department of Gastrointestinal and Pediatric Surgery

ytoi0725@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026